<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We investigated retrospectively 992 children with central <z:mp ids='MP_0008912'>nervous</z:mp> system <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> who were treated at our center between 1970 and 2004 </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> of the patients were treated by surgery, chemotherapy, and/or radiotherapy </plain></SENT>
<SENT sid="2" pm="."><plain>Six patients developed second malignant <z:hpo ids='HP_0002664'>neoplasms</z:hpo>, and their clinical and histopathologic characteristics are reviewed in this article </plain></SENT>
<SENT sid="3" pm="."><plain>The second malignant <z:hpo ids='HP_0002664'>neoplasms</z:hpo> were diagnosed as non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo>, <z:hpo ids='HP_0002671'>basal cell carcinoma</z:hpo>, <z:hpo ids='HP_0002861'>malignant melanoma</z:hpo>, Kaposi <z:hpo ids='HP_0100242'>sarcoma</z:hpo>, and high-grade <z:e sem="disease" ids="C0206093" disease_type="Neoplastic Process" abbrv="">neuroectodermal tumor</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The initial diagnoses were <z:e sem="disease" ids="C0700367" disease_type="Neoplastic Process" abbrv="">ependymoblastoma</z:e> in one, <z:hpo ids='HP_0002885'>medulloblastoma</z:hpo> in three, and low-grade <z:hpo ids='HP_0009592'>astrocytoma</z:hpo> in two patients </plain></SENT>
<SENT sid="5" pm="."><plain>The median latency time was 3.03 years (range 0.39-22.93 years) </plain></SENT>
<SENT sid="6" pm="."><plain>The outcome varied according to the histopathologic type of the second <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>The patients who developed non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> died of progressive disease </plain></SENT>
<SENT sid="8" pm="."><plain>The patients with second skin <z:hpo ids='HP_0002664'>neoplasms</z:hpo> are alive as of the time of this writing </plain></SENT>
<SENT sid="9" pm="."><plain>The patient with Kaposi <z:hpo ids='HP_0100242'>sarcoma</z:hpo> developed one of the rare reported second malignant <z:hpo ids='HP_0002664'>neoplasms</z:hpo> following a primary <z:mp ids='MP_0009277'>brain tumor</z:mp> in childhood </plain></SENT>
<SENT sid="10" pm="."><plain>A wide spectrum of second malignant <z:hpo ids='HP_0002664'>neoplasms</z:hpo> was detected after treatment of primary <z:mp ids='MP_0009277'>brain tumors</z:mp> with surgery, radiotherapy, and chemotherapy </plain></SENT>
<SENT sid="11" pm="."><plain>Long-term follow-up is therefore necessary for the child who has survived a primary central <z:mp ids='MP_0008912'>nervous</z:mp> system <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> </plain></SENT>
</text></document>